HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Do patients with demyelinating disease have antibodies against human glial cells in their sera?

Abstract
Cell-type-specific markers and indirect immunofluorescence were used to study immunoglobulin binding to glial cells in dissociated cell cultures of human foetal optic nerve, spinal cord and dorsal root ganglion in sera from patients with demyelinating diseases, other neurological diseases and normal controls. These various sera proved to be indistinguishable in that almost all of them contained immunoglobulin which bound weakly to all oligodendrocytes and fibroblasts, 5-25% of astrocytes and about 50% of Schwann cells.
AuthorsP G Kennedy, R P Lisak
JournalJournal of neurology, neurosurgery, and psychiatry (J Neurol Neurosurg Psychiatry) Vol. 44 Issue 2 Pg. 164-7 (Feb 1981) ISSN: 0022-3050 [Print] England
PMID7012279 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
Topics
  • Astrocytes (immunology)
  • Autoantibodies (analysis)
  • Cells, Cultured
  • Demyelinating Diseases (immunology)
  • Fibroblasts (immunology)
  • Fluorescent Antibody Technique
  • Ganglia, Spinal (immunology)
  • Humans
  • Neuroglia (immunology)
  • Oligodendroglia (immunology)
  • Optic Nerve (immunology)
  • Schwann Cells (immunology)
  • Spinal Cord (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: